Otero Jose Manuel 4
4 · Lexeo Therapeutics, Inc. · Filed Jul 1, 2026
Research Summary
AI-generated summary of this filing
Lexeo (LXEO) COO Jose Otero Sells 4,666 Shares
What Happened
Jose Manuel Otero, Chief Operating Officer of Lexeo Therapeutics (LXEO), received an award of 12,060 restricted stock units (RSUs) on 2026-06-29 (reported as acquired at $0.00). On 2026-07-01 he disposed of 4,666 shares in an open-market sale at a weighted-average price of $4.48 per share for total proceeds of $20,904. The filing indicates the sale was executed to cover tax obligations related to the RSU release.
Key Details
- Transactions reported: Award (A) — 12,060 RSUs on 2026-06-29; Sale (S) — 4,666 shares on 2026-07-01.
- Sale price: weighted average $4.48; individual trades ranged $4.35–$4.73 (footnote F2).
- Purpose of sale: tax withholding on RSU release (footnote F1).
- Holdings after transaction: the filing does not list total common shares beneficially owned; it notes inclusion of 100,621 RSUs (footnote F3).
- Timeliness: Form 4 filed 2026-07-01 (same day as sale) — appears timely.
Context
RSUs are a contingent right to receive shares in the future; the award was reported at $0 because it is an equity grant rather than a cash purchase. The sale here was a routine "sell-to-cover" for taxes and should be viewed as fulfilling withholding obligations rather than a clear signal of the insider's market view.
Insider Transaction Report
- Award
Common Stock
2026-06-29+12,060→ 142,148 total - Sale
Common Stock
[F1][F2][F3]2026-07-01$4.48/sh−4,666$20,904→ 137,482 total
Footnotes (3)
- [F1]Represents a sale to cover tax obligations on the release of performance Restricted Stock Units ("RSUs").
- [F2]This transaction was executed in multiple trades at prices ranging from $4.35 to $4.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Includes 100,621 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.